Q-Line Biotech Limited IPO
Listed · SME · NSE SME
Last updated: · Compiled by IPONOVA Editorial Desk · How we source data
IPO Details
| Price Band | ₹326.00–₹326.00 |
|---|---|
| Lot Size | 400 shares |
| Issue Size | ₹214cr |
| Open Date | 21 May 26 |
| Close Date | 25 May 26 |
| Listing Date | 29 May 26 |
| Exchange | NSE SME |
| Subscription | 102.42x |
About Q-Line Biotech Limited
Q-Line Biotech Limited is an in-vitro diagnostics (IVD) company engaged in the manufacturing and trading of biochemistry reagents, diagnostic instruments and consumables used in healthcare testing and laboratory applications. The company operates multiple manufacturing facilities in Uttar Pradesh and Delhi and offers products across categories such as ELISA, molecular diagnostics, chemiluminescence immunoassay (CLIA), immuno fluorescence assay (IFA), nucleic acid extraction kits and PCR-based diagnostic kits. Its product portfolio includes tests for infectious diseases, thyroid disorders, cardiac markers and other clinical conditions. The company generates revenue primarily through the sale of its diagnostic products and instruments, largely through a network of distributors, including group entity POCT Services. Q-Line Biotech also focuses on research and development through its subsidiary, Q-Line Innovations Private Limited, which works on developing diagnostic and scientific equipment and consumables.
Anchor Investor Allotment
| Anchor Investor Name | Eq. Shares | Allocation % | Bid Price | Investment Amount | 30-Day Lock-in | 90-Day Lock-in |
|---|---|---|---|---|---|---|
| Abakkus Small Cap Fund | 291,600 | 16.37% | ₹343.00 | ₹10.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Carnelian AIF Category I Trust - Scheme 1 | 281,600 | 15.81% | ₹343.00 | ₹9.66 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Abakkus Flexi Edge Fund-I | 227,600 | 12.78% | ₹343.00 | ₹7.81 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Bharat Venture Opportunities Fund | 200,000 | 11.23% | ₹343.00 | ₹6.86 Cr | 09 Jul 2026 | 05 Oct 2026 |
| India Max Investment Fund Limited | 143,200 | 8.04% | ₹343.00 | ₹4.91 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Sanshi Fund-I | 143,200 | 8.04% | ₹343.00 | ₹4.91 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Meru Investment Fund PCC-Cell 1 | 87,600 | 4.92% | ₹343.00 | ₹3.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Tiger Strategies Fund -I | 58,400 | 3.28% | ₹343.00 | ₹2.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Finavenue Capital Trust - Finavenue Growth Fund | 57,200 | 3.21% | ₹343.00 | ₹1.96 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Hem Growth Opportunities Fund | 57,200 | 3.21% | ₹343.00 | ₹1.96 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Tattvam AIF Trust - Aanjay Ageless AIF Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| 360 One LVF Treasury Solutions Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| HDFC Bank Limited | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Innovative Vision Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Navbharat Investment Trust - Navbharat Investment Opportunities Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Rajasthan Global Securities Private Limited | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Religo Commodities Ventures Trust - Religo Commodities Ventures Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| Sunrise Investment Trust - Sunrise Investment Opportunities Fund | 29,200 | 1.64% | ₹343.00 | ₹1.00 Cr | 09 Jul 2026 | 05 Oct 2026 |
| TOTAL (18 investors) | 1,781,200 | 100.01% | ₹61.10 Cr | |||
Lock-in dates calculated from allotment date (30 & 90 calendar days, adjusted to next NSE trading day as per exchange holiday calendar).
For live subscription data, allotment status and full IPO analysis, visit IPONOVA — India's IPO Intelligence Platform.
Frequently Asked Questions
- When does the Q-Line Biotech Limited IPO open and close?
- The Q-Line Biotech Limited IPO opens for subscription on 21 May 26. It closes on 25 May 26.
- What is the price band of Q-Line Biotech Limited IPO?
- The price band of Q-Line Biotech Limited IPO is ₹326.00 to ₹326.00 per share.
- What is the minimum lot size for Q-Line Biotech Limited IPO?
- The minimum lot size for Q-Line Biotech Limited IPO is 400 shares, requiring a minimum investment of ₹130,400.
- When will Q-Line Biotech Limited list on stock exchanges?
- Q-Line Biotech Limited is expected to list on NSE SME on 29 May 26.
- How can I check Q-Line Biotech Limited IPO allotment status?
- You can check Q-Line Biotech Limited IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
- How to apply for Q-Line Biotech Limited IPO?
- You can apply for Q-Line Biotech Limited IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹326.00 to ₹326.00 per share.
Data Sources & Verification
This page aggregates publicly available data for the Q-Line Biotech Limited IPO from the following authoritative sources:
- SEBI — Red Herring Prospectus (RHP) and regulatory filings · sebi.gov.in
- BSE Limited — Issue circulars, subscription data, listing notices · bseindia.com
- National Stock Exchange of India (NSE) — Public issue data, listing data · nseindia.com
- Registrar to the Issue — Allotment status (Link Intime, KFin Technologies, Bigshare Services, MUFG Intime)
Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.